← Insider Monitor
BeOne Medicines Ltd. logo
ONC

BeOne Medicines Ltd.

Nasdaq · Pharmaceutical Preparations

20
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

BeOne Medicines (formerly BeiGene) develops and markets cancer therapies, including its own discovered drugs such as the BTK inhibitor Brukinsa and the PD-1 inhibitor tislelizumab, alongside a pipeline of other oncology treatments. The company operates global R&D and manufacturing operations across the U.S., China, Switzerland, and other markets.

Industry
Pharmaceutical Preparations
Headquarters
Basel
Exchange
Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
Ball Titus B.Principal Accounting OfficerSell$11KNov 6, 2026
Ball Titus B.Principal Accounting OfficerSell$622KNov 6, 2026
Lee Chan HenrySVP, General CounselSell$264KNov 5, 2026
Lee Chan HenrySVP, General CounselSell$183KNov 5, 2026
Wang XiaodongDirectorSell$460KOct 27, 2026
Wang XiaodongDirectorSell$603KOct 27, 2026
Wang XiaodongDirectorSell$115KOct 27, 2026
Wang XiaodongDirectorSell$845KOct 27, 2026
Wang XiaodongDirectorSell$2.96MOct 27, 2026
Wang XiaodongDirectorSell$1.03MOct 27, 2026
Wang XiaodongDirectorSell$1.45MOct 27, 2026
Wang XiaodongDirectorSell$2.53MOct 27, 2026
Wang XiaodongDirectorSell$313KOct 27, 2026
Wang XiaodongDirectorSell$512KOct 27, 2026
Wang XiaodongDirectorSell$443KOct 27, 2026
Wang XiaodongDirectorSell$3.63MOct 13, 2026
Wang XiaodongDirectorSell$445KOct 13, 2026
Wang XiaodongDirectorSell$2.51MOct 13, 2026
Wang XiaodongDirectorSell$2.31MOct 13, 2026
Wang XiaodongDirectorSell$2.00MOct 13, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for ONC.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable ONC activity by email

Free alerts for the insider and congressional trades worth watching.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.